Business Context and Reporting Period
This Form 8-K filing by Lazard Ltd (Lazard) is dated March 30, 2006, with the earliest event reported on March 31, 2006. The filing primarily addresses the termination of a strategic alliance and joint venture with Banca Intesa S.p.A. (Intesa) regarding their investment banking operations in Italy, which had been in effect since January 2003.
Key Financial Metrics and Obligations
The filing details specific financial instruments and obligations resulting from the termination agreement:
- Convertible Note Restructuring: A $150 million subordinated convertible note held by Intesa will be amended. It will mature in September 2016 with a fixed interest rate of 3.25%. It becomes convertible into Lazard Ltd Class A common stock at $57 per share, with conversion windows opening in July 2008, 2009, and 2010, and closing after June 30, 2011.
- Joint Venture Buyout: Lazard Group will acquire Intesa's 40% interest in Lazard Italy and a $50 million subordinated promissory note. In exchange, Lazard will issue a $96 million senior promissory note (4.25% interest) and a $50 million subordinated promissory note (4.6% interest), both due February 28, 2008.
- Additional Payments: Lazard will pay Intesa a 3% annualized return on the joint venture interest from April 1, 2006, through closing, plus accrued interest on the $50 million note. Intesa will remit any 2005 dividends received on the joint venture interest to Lazard.
The filing does not provide current revenue, profit, cash flow, or liquidity metrics for the reporting period.
Material Changes Versus Prior Period
The primary material change is the restructuring of the relationship with Intesa. Previously, the alliance was set to expire on December 31, 2007, at which point Lazard would have been obligated to acquire Intesa's interests for up to $150 million in cash. Under the new Termination Agreement:
- The joint venture relationship and Master Agreement are terminated immediately upon closing.
- The $150 million note is converted from a goodwill interest instrument to a direct equity conversion instrument.
- The buyout of the Italian joint venture is accelerated and structured via new debt instruments rather than a single cash payment in 2008.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The transaction is expected to close promptly after receipt of required regulatory approvals and satisfaction of customary closing conditions. The filing notes that Intesa previously notified Lazard of its intention not to extend the joint venture beyond 2007, prompting these negotiations.
Risks and Contingencies: The closing of the termination agreement is contingent upon regulatory approvals. The filing also notes the death of Dr. John K. Shank, a director and member of the Audit Committee, on March 30, 2006, which may impact board composition and oversight.
Key Facts for Investor Verification
- Verify the status of regulatory approvals required to close the Termination Agreement with Intesa.
- Confirm the impact of the new $146 million in debt obligations ($96 million senior + $50 million subordinated) on Lazard's leverage ratios and liquidity.
- Monitor the potential dilution from the conversion of the $150 million note into Lazard Ltd common stock at $57 per share.
- Check for the appointment of a new director to replace Dr. John K. Shank on the Audit Committee.